Multi-institutional team awarded NCI grant to open novel AML trial
Grant and Award Announcement
Updates every hour. Last Updated: 4-Nov-2025 21:11 ET (5-Nov-2025 02:11 GMT/UTC)
The University of Cincinnati Cancer Center (UC), The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and Jabez Biosciences are partnering to open a new phase 1 clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia (AML).
A Columbia study addresses a key challenge in the diagnosis of rare genetic disorders.